靜脈曲張治療市場規模、佔有率和成長分析：按類型、產品、最終用途和地區 - 2024-2031 年行業預測

靜脈曲張治療市場規模預計2023年為13.8億美元，從2024年的14.7億美元成長到2032年的24億美元，複合年成長率預計將成長6.32%。

全球靜脈曲張治療市場經歷了顯著成長，隨著人口老化、久坐的生活方式和肥胖增加了這種常見疾病的盛行率，預計將繼續擴大。市場正在轉向微創治療，如內源性雷射消熔、硬化療法和射頻消融術，與傳統手術相比，這些治療具有減輕疼痛和加速恢復時間等優點。最近的技術進步，包括超音波導引的泡沫硬化療法，改善了患者的治療效果和滿意度。然而，報銷問題、高昂的治療費用和認知不足等挑戰可能會限制可及性，特別是在發展中地區。隨著公司專注於創新，競爭格局正在加劇，需要持續投資於研究和監管合規性，以有效地將新解決方案推向市場。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 宏觀經濟指標
• 價值鏈分析
• 價格分析

按類型分類的靜脈曲張治療市場規模

• 市場概況
• 靜脈消融
  • 靜脈雷射治療
  • 射頻消融術
• 注射硬化療法
• 手術結紮和剝離

靜脈曲張治療市場規模：依產品

• 市場概況
• 消融裝置
• 射頻消融術裝置
• 雷射消熔裝置
• 靜脈縫合產品

以最終用途分類的靜脈曲張治療市場規模

• 市場概況
• 醫院
• 門診手術中心
• 專科診所

靜脈曲張治療市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• Medtronic plc（Ireland）
• AngioDynamics, Inc.（USA）
• Teleflex Incorporated（USA）
• Boston Scientific Corporation（USA）
• Lumenis Ltd.（Israel）
• Quanta System SpA（Italy）
• Biolitec AG（Austria）
• Dornier MedTech GmbH（Germany）
• Sciton, Inc.（USA）
• Fotona doo（Slovenia）
• Viatris Inc.（USA）
• Merz Aesthetics（USA）
• SIGVARIS Group（Switzerland）
• Essity Aktiebolag（publ）（Sweden）
• F Care Systems NV（Belgium）
• VVT Medical（Israel）
• Alma Lasers（Israel）
• Energist Group（UK）.
• Eufoton srl（Italy）
• WONTECH Co., Ltd.（South Korea）

結論和建議

Varicose Veins Treatment Market size was valued at USD 1.38 Billion in 2023 and is poised to grow from USD 1.47 Billion in 2024 to USD 2.4 Billion by 2032, growing at a CAGR of 6.32% during the forecast period (2025-2032).

The global varicose veins treatment market is witnessing remarkable growth and is projected to continue its expansion due to the increasing prevalence of this common condition, spurred by an aging population, sedentary lifestyles, and obesity. The market is shifting towards minimally invasive treatments like endogenous laser ablation, sclerotherapy, and radiofrequency ablation, which offer benefits such as reduced pain and shorter recovery times compared to traditional surgery. Recent technological advancements, including ultrasound-guided foam sclerotherapy, are enhancing patient outcomes and satisfaction. However, challenges such as reimbursement issues, high treatment costs, and inadequate awareness can limit accessibility, particularly in developing regions. The competitive landscape is intensifying as companies focus on innovation, necessitating ongoing investment in research and regulatory compliance to bring new solutions to market effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Varicose Veins Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Varicose Veins Treatment Market Segmental Analysis

Global Varicose Veins Treatment Market is segmented by type, products, end use and region. Based on type, the market is segmented into endovenous ablation, injection sclerotherapy and surgical ligation & stripping. Based on products, the market is segmented into ablation devices, radiofrequency ablation devices, laser ablation devices and venous closure products. Based on end use, the market is segmented into hospitals, ambulatory surgical centers and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Varicose Veins Treatment Market

The Varicose Veins Treatment market is being propelled by a surge in awareness and education concerning varicose veins and the treatment options available. With public awareness campaigns, educational initiatives, and the widespread dissemination of information through various platforms, more individuals are becoming informed about their conditions. This increased knowledge empowers patients to take action and seek appropriate treatment for their varicose veins. As a result, the combination of heightened awareness and patient education is fostering a growing demand in the market, leading to an increase in the number of individuals pursuing effective treatment solutions to address their varicose vein issues.

Restraints in the Varicose Veins Treatment Market

The varicose veins treatment market faces significant restraints due to regulatory challenges. Manufacturers must navigate complex regulatory requirements and approval processes, which can vary widely across different countries. This intricacy can lead to delays and increased costs, hampering the timely introduction of new treatments and innovations. Consequently, the burden of regulatory compliance may deter companies from pursuing advancements in the field, ultimately limiting options for patients seeking effective solutions. As a result, the overall growth and development of the varicose veins treatment market may be adversely impacted, creating obstacles for both manufacturers and healthcare providers alike.

Market Trends of the Varicose Veins Treatment Market

The varicose veins treatment market is experiencing a significant shift towards combination therapies, which are becoming increasingly popular due to their ability to optimize treatment outcomes. Combining modalities like endovenous ablation with sclerotherapy allows for a comprehensive approach, effectively targeting various facets of venous disease. This trend not only enhances the efficacy of treatments but also boosts patient satisfaction, leading to a more favorable perception of varicose vein options. As healthcare providers look to maximize results and improve the overall patient experience, the adoption of combination therapies is expected to drive market growth and innovation in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Varicose Veins Treatment Market Size by Type & CAGR (2025-2032)

• Market Overview
• Endovenous Ablation
  • Endovenous Laser Therapy
  • Radiofrequency Ablation
• Injection Sclerotherapy
• Surgical Ligation & Stripping

Global Varicose Veins Treatment Market Size by Products & CAGR (2025-2032)

• Market Overview
• Ablation Devices
• Radiofrequency Ablation Devices
• Laser Ablation Devices
• Venous Closure Products

Global Varicose Veins Treatment Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Global Varicose Veins Treatment Market Size & CAGR (2025-2032)

• North America (Type, Products, End Use)
  • US
  • Canada
• Europe (Type, Products, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Products, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Products, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Products, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lumenis Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quanta System S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolitec AG (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dornier MedTech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sciton, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fotona d.o.o. (Slovenia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Aesthetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SIGVARIS Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Essity Aktiebolag (publ) (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F Care Systems NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VVT Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alma Lasers (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Energist Group (UK).
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eufoton s.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WONTECH Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations